Essential role of PSM/SH2-B variants in insulin receptor catalytic activation and the resulting cellular responses

Journal of Cellular Biochemistry

Volumn 103, Issue 1, 2008, Pages 162-181

  Zhang, Manchao ^a   Deng, Youping ^b   Tandon, Ruchi ^c   Bai, Cheng ^c   Riedel, Heimo ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b The University of Southern Mississippi   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

Cell permeant peptide; Dimerization; Insulin action; Internal ligand; Metabolism; PH; Pro rich; SH2 B

Indexed keywords

CBL PROTEIN; GLUCOSE; GLYCOGEN SYNTHASE; GLYCOGEN SYNTHASE KINASE 3; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; PLECKSTRIN; PROTEIN KINASE B; PROTEIN SH2; PROTEIN SH2B; S6 KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CATALYSIS; CELL STRAIN 3T3; CONTROLLED STUDY; DIMERIZATION; GENE DISRUPTION; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; INSULIN RESPONSE; LIPOGENESIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY;

3T3 CELLS; ADENOSINE TRIPHOSPHATE; ANIMALS; CATALYSIS; ENZYME ACTIVATION; GLYCOGEN SYNTHASE KINASE 3; INSULIN; JANUS KINASE 2; KINETICS; MICE; PHYLOGENY; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-CBL; RECEPTOR, INSULIN; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY;

MUS;

EID: 38149062582     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21397     Document Type: Article

References (70)

1. Ahmed Z, Pillay TS. 2001. Functional effects of APS and SH2-B on insulin receptor signaling. Biochem Soc Trans 29:529-534.
2. Ahmed Z, Pillay TS. 2003. Adapter protein with a pleckstrin homology (PH) and an Src homology 2 (SH2) domain (APS) and SH2-B enhance insulin-receptor autophosphorylation, extracellular-signal-regulated kinase and phosphoinositide 3-kinase-dependent signaling. Biochem J 371:405-412.
3. Ahmed Z, Smith BJ, Pillay TS. 2000. The APS adapter protein couples the insulin receptor to the phosphorylation of c-Cbl and facilitates ligand-stimulated ubiquitination of the insulin receptor. FEBS Lett 475:31-34.
4. Ahn MY, Katsanakis KD, Bheda F, Pillay TS. 2004. Primary and essential role of the adaptor protein APS for recruitment of both c-Cbl and its associated protein CAP in insulin signaling. J Biol Chem 279:21526-21532.
5. Bak JF, Handberg A, Beck-Nielsen H, Pedersen O. 1990. Kinetics of insulin binding and kinase activity of the partially purified insulin receptor from human skeletal muscle. Biochim Biophys Acta 1052:306-312.
6. Carter-Su C, Rui L, Herrington J. 2000a. Role of the tyrosine kinase JAK2 in signal transduction by growth hormone. Pediatr Nephrol 14:550-557.
7. Carter-Su C, Rui L, Stofega MR. 2000b. SH2-B and SIRP: JAK2 binding proteins that modulate the actions of growth hormone. Recent Prog Horm Res 55:293-311.
8. Chen L, Carter-Su C. 2004. Adapter protein SH2-B beta undergoes nucleocytoplasmic shuttling: Implications for nerve growth factor induction of neuronal differentiation. Mol Cell Biol 24:3633-3647.
9. Deng Y, Bhattacharya S, Swamy OR, Tandon R, Wang Y, Janda R, Riedel H. 2003. Growth factor receptor-binding protein 10 (Grb10) as a partner of phosphatidylinositol 3-kinase in metabolic insulin action. J Biol Chem 278:39311-39322.
10. Deng Y, Xu H, Riedel H. 2007. PSM/SH2-B distributes selected mitogenic receptor signals to distinct components in the PI3-kinase and MAP kinase signaling pathways. J Cell Biochem 100:557-573.
11. Dhe-Paganon S, Werner ED, Nishi M, Hansen L, Chi YI, Shoelson SE. 2004. A phenylalanine zipper mediates APS dimerization. Nat Struct Mol Biol 11:968-974.
12. Diakonova M, Gunter DR, Herrington J, Carter-Su C. 2002. SH2-Bbeta is a Rac-binding protein that regulates cell motility. J Biol Chem 277:10669-10677.
13. Duan C, Li M, Rui L. 2004a. SH2-B promotes insulin receptor substrate 1 (IRS1)- and IRS2-mediated activation of the phosphatidylinositol 3-kinase pathway in response to leptin. J Biol Chem 279:43684-43691.
14. Duan C, Yang H, White MF, Rui L. 2004b. Disruption of the SH2-B gene causes age-dependent insulin resistance and glucose intolerance. Mol Cell Biol 24:7435-7443.
15. Eggert A, Ikegaki N, Liu X, Chou TT, Lee VM, Trojanowski JQ, Brodeur GM. 2000. Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells. Oncogene 19:2043-2051.
16. Herrington J, Diakonova M, Rui L, Gunter DR, Carter-Su C. 2000. SH2-B is required for growth hormone-induced actin reorganization. J Biol Chem 275:13126-13133.
17. Hu J, Hubbard SR. 2006. Structural basis for phosphotyrosine recognition by the Src homology-2 domains of the adapter proteins SH2-B and APS. J Mol Biol 361:69-79.
18. Huang X, Li Y, Tanaka K, Moore KG, Hayashi JI. 1995. Cloning and characterization of Lnk, a signal transduction protein that links T-cell receptor activation signal to phospholipase C gamma 1, Grb2, and phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA 92:11618-11622.
19. Iseki M, Takaki S, Takatsu K. 2000. Molecular cloning of the mouse APS as a member of the Lnk family adaptor proteins. Biochem Biophys Res Commun 272:45-54.
20. Jamshidi Y, Snieder H, Ge D, Spector TD, O'Dell SD. 2007. The SH2B gene is associated with serum leptin and body fat in normal female twins. Obesity (Silver Spring) 15:5-9.
21. JeBailey L, Rudich A, Huang X, Di Ciano-Oliveira C, Kapus A, Klip A. 2004. Skeletal muscle cells and adipocytes differ in their reliance on TC10 and Rac for insulin-induced actin remodeling. Mol Endocrinol 18:359-372.
22. Katsanakis KD, Pillay TS. 2005. Cross-talk between the two divergent insulin signaling pathways is revealed by the protein kinase B (Akt)-mediated phosphorylation of adapter protein APS on serine 588. J Biol Chem 280:37827-37832.
23. Koch A, Mancini A, Stefan M, Niedenthal R, Niemann H, Tamura T. 2000. Direct interaction of nerve growth factor receptor, TrkA, with non-receptor tyrosine kinase, c-Abl, through the activation loop. FEBS Lett 469:72-76.
24. Kong M, Wang CS, Donoghue DJ. 2002. Interaction of fibroblast growth factor receptor 3 and the adapter protein SH2-B. A role in STAT5 activation. J Biol Chem 277:15962-15970.
25. Kotani K, Wilden P, Pillay TS. 1998. SH2-Balpha is an insulin-receptor adapter protein and substrate that interacts with the activation loop of the insulin-receptor kinase. Biochem J 335(Pt 1):103-109.
26. Kubo-Akashi C, Iseki M, Kwon SM, Takizawa H, Takatsu K, Takaki S. 2004. Roles of a conserved family of adaptor proteins, Lnk, SH2-B, and APS, for mast cell development, growth, and functions: APS-deficiency causes augmented degranulation and reduced actin assembly. Biochem Biophys Res Commun 315:356-362.
27. Kurzer JH, Argetsinger LS, Zhou YJ, Kouadio JL, O'Shea JJ, Carter-Su C. 2004. Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-B beta. Mol Cell Biol 24:4557-4570.
28. Kurzer JH, Saharinen P, Silvennoinen O, Carter-Su C. 2006. Binding of SH2-B family members within a potential negative regulatory region maintains JAK2 in an active state. Mol Cell Biol 26:6381-6394.
29. Li CH, Moule ML, Yip CC. 1991. Insulin receptors prepared with iodoacetamide show enhanced autophosphorylation and receptor kinase activity. J Biol Chem 266:7051-7057.
30. Li M, Ren D, Iseki M, Takaki S, Rui L. 2006. Differential role of SH2-B and APS in regulating energy and glucose homeostasis. Endocrinology 147:2163-2170.
31. Li M, Li Z, Morris DL, Rui L. 2007. Identification of SH2B2{beta} as an Inhibitor for SH2B1- and SH2B2{alpha}-promoted JAK2 Activation and Insulin Signaling. Endocrinology 148:1615-1621.
32. Maures TJ, Kurzer JH, Carter-Su C. 2006. SH2B1 (SH2-B) and JAK2: A multifunctional adaptor protein and kinase made for each other. Trends Endocrinol Metab 18:38-45.
33. McDowell HE, Eyers PA, Hundal HS. 1998. Regulation of System A amino acid transport in L6 rat skeletal muscle cells by insulin, chemical, and hyperthermic stress. FEBS Lett 441:15-19.
34. Minami A, Iseki M, Kishi K, Wang M, Ogura M, Furukawa N, Hayashi S, Yamada M, Obata T, Takeshita Y, Nakaya Y, Bando Y, Izumi K, Moodie SA, Kajiura F, Matsumoto M, Takatsu K, Takaki S, Ebina Y. 2003. Increased insulin sensitivity and hypoinsulinemia in APS knockout mice. Diabetes 52:2657-2665.
35. Miquet JG, Sotelo AI, Bartke A, Turyn D. 2005. Increased SH2-Bbeta content and membrane association in transgenic mice overexpressing GH. J Endocrinol 185:301-306.
36. Moodie SA, Alleman-Sposeto J, Gustafson TA. 1999. Identification of the APS protein as a novel insulin receptor substrate. J Biol Chem 274:11186-11193.
37. Nelms K, O'Neill TJ, Li S, Hubbard SR, Gustafson TA, Paul WE. 1999. Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain. Mamm Genome 10:1160-1167.
38. Nishi M, Werner ED, Oh BC, Frantz JD, Dhe-Paganon S, Hansen L, Lee J, Shoelson SE. 2005. Kinase activation through dimerization by human SH2-B. Mol Cell Biol 25:2607-2621.
39. O'Brien KB, O'Shea JJ, Carter-Su C. 2002. SH2-B family members differentially regulate JAK family tyrosine kinases. J Biol Chem 277:8673-8681.
40. O'Brien KB, Argetsinger LS, Diakonova M, Carter-Su C. 2003. YXXL motifs in SH2-Bbeta are phosphorylated by JAK2. JAK1, and platelet-derived growth factor receptor and are required for membrane ruffling. J Biol Chem 278:11970-11978.
41. Ohtsuka S, Takaki S, Iseki M, Miyoshi K, Nakagata N, Kataoka Y, Yoshida N, Takatsu K, Yoshimura A. 2002. SH2-B is required for both male and female reproduction. Mol Cell Biol 22:3066-3077.
42. Osborne MA, Dalton S, Kochan JP. 1995. The yeast tribrid system-genetic detection of trans-phosphorylated ITAM-SH2-interactions. Biotechnology (NY) 13:1474-1478.
43. Qian X, Ginty DD. 2001. SH2-B and APS are multimeric adapters that augment TrkA signaling. Mol Cell Biol 21:1613-1620.
44. Qian X, Riccio A, Zhang Y, Ginty DD. 1998. Identification and characterization of novel substrates of Trk receptors in developing neurons. Neuron 21:1017-1029.
45. Ren D, Zhou Y, Morris D, Li M, Li Z, Rui L. 2007. Neuronal SH2B1 is essential for controlling energy and glucose homeostasis. J Clin Invest 117:397-406.
46. Riedel H, Wang J, Hansen H, Yousaf N. 1997. PSM, an insulin-dependent, pro-rich, PH, SH2 domain containing partner of the insulin receptor. J Biochem (Tokyo) 122:1105-1113.
47. Riedel H, Yousaf N, Zhao Y, Dai H, Deng Y, Wang J. 2000. PSM, a mediator of PDGF-BB-, IGF-I-, and insulin-stimulated mitogenesis. Oncogene 19:39-50.
48. Rudd CE. 2001. Lnk adaptor: Novel negative regulator of B cell lymphopoiesis. Sci STKE 2001: PE1.
49. Rui L, Carter-Su C. 1998. Platelet-derived growth factor (PDGF) stimulates the association of SH2-Bbeta with PDGF receptor and phosphorylation of SH2-Bbeta. J Biol Chem 273:21239-21245.
50. Rui L, Carter-Su C. 1999. Identification of SH2-bbeta as a potent cytoplasmic activator of the tyrosine kinase Janus kinase 2. Proc Natl Acad Sci USA 96:7172-7177.
51. Rui L, Mathews LS, Hotta K, Gustafson TA, Carter-Su C. 1997. Identification of SH2-Bbeta as a substrate of the tyrosine kinase JAK2 involved in growth hormone signaling. Mol Cell Biol 17:6633-6644.
52. Rui L, Herrington J, Carter-Su C. 1999. SH2-B, a membrane-associated adapter, is phosphorylated on multiple serines/threonines in response to nerve growth factor by kinases within the MEK/ERK cascade. J Biol Chem 274:26485-26492.
53. Rui L, Gunter DR, Herrington J, Carter-Su C. 2000. Differential binding to and regulation of JAK2 by the SH2 domain and N-terminal region of SH2-bbeta. Mol Cell Biol 20:3168-3177.
54. Saltiel AR, Pessin JE. 2002. Insulin signaling pathways in time and space. Trends Cell Biol 12:65-71.
55. Sharma PM, Egawa K, Huang Y, Martin JL, Huvar I, Boss GR, Olefsky JM. 1998. Inhibition of phosphatidylinositol 3-kinase activity by adenovirus-mediated gene transfer and its effect on insulin action. J Biol Chem 273:18528-18537.
56. Standaert ML, Sajan MP, Miura A, Bandyopadhyay G, Farese RV. 2004. Requirements for pYXXM motifs in Cbl for binding to the p85 subunit of phosphatidylinositol 3-kinase and Crk, and activation of atypical protein kinase C and glucose transport during insulin action in 3T3/L1 adipocytes. Biochemistry 43:15494-15502.
57. Suzuki K, Mizutani M, Hitomi Y, Kizaki T, Ohno H, Ishida H, Haga S, Koizumi S. 2002. Association of SH2-B to phosphorylated tyrosine residues in the activation loop of TrkB. Res Commun Mol Pathol Pharmacol 111:27-39.
58. Tennagels N, Bergschneider E, Al-Hasani H, Klein HW. 2000. Autophosphorylation of the two C-terminal tyrosine residues Tyr1316 and Tyr1322 modulates the activity of the insulin receptor kinase in vitro. FEBS Lett 479:67-71.
59. Velazquez L, Cheng AM, Fleming HE, Furlonger C, Vesely S, Bernstein A, Paige CJ, Pawson T. 2002. Cytokine signaling and hematopoietic homeostasis are disrupted in Lnk-deficient mice. J Exp Med 195:1599-1611.
60. Wada T, Sasaoka T, Funaki M, Hori H, Murakami S, Ishiki M, Haruta T, Asano T, Ogawa W, Ishihara H, Kobayashi M. 2001. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5′-phosphatase catalytic activity. Mol Cell Biol 21:1633-1646.
61. Wadia JS, Dowdy SF. 2005. Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer. Adv Drug Deliv Rev 57:579-596.
62. Wang J, Riedel H. 1998. Insulin-like growth factor-I receptor and insulin receptor association with a Src homology-2 domain-containing putative adapter. J Biol Chem 273:3136-3139.
63. Wang J, Dai H, Yousaf N, Moussaif M, Deng Y, Boufelliga A, Swamy OR, Leone ME, Riedel H. 1999. Grb10, a positive, stimulatory signaling adapter in platelet-derived growth factor BB-, insulin-like growth factor I-, and insulin-mediated mitogenesis. Mol Cell Biol 19: 6217-6228.
64. Wang X, Chen L, Maures TJ, Herrington J, Carter-Su C. 2004. SH2-B is a positive regulator of nerve growth factor-mediated activation of the Akt/Forkhead pathway in PC12 cells. J Biol Chem 279:133-141.
65. White MF, Haring HU, Kasuga M, Kahn CR. 1984. Kinetic properties and sites of autophosphorylation of the partially purified insulin receptor from hepatoma cells. J Biol Chem 259:255-264.
66. Wiese RJ, Mastick CC, Lazar DF, Saltiel AR. 1995. Activation of mitogen-activated protein kinase and phosphatidylinositol 3′-kinase is not sufficient for the hormonal stimulation of glucose uptake, lipogenesis, or glycogen synthesis in 3T3-L1 adipocytes. J Biol Chem 270:3442-3446.
67. Yokouchi M, Suzuki R, Masuhara M, Komiya S, Inoue A, Yoshimura A. 1997. Cloning and characterization of APS, an adaptor molecule containing PH and SH2 domains that is tyrosine phosphorylated upon B-cell receptor stimulation. Oncogene 15:7-15.
68. Yoshiga D, Sato N, Torisu T, Mori H, Yoshida R, Nakamura S, Takaesu G, Kobayashi T, Yoshimura A. 2007. Adaptor protein SH2-B linking receptor-tyrosine kinase and Akt promotes adipocyte differentiation by regulating PPAR{-gamma} mRNA levels. Mol Endocrinol.
69. Yousaf N, Deng Y, Kang Y, Riedel H. 2001. Four PSM/SH2-B alternative splice variants and their differential roles in mitogenesis. J Biol Chem 276:40940-40948.
70. Zhou QL, Park JG, Jiang ZY, Holik JJ, Mitra P, Semiz S, Guilherme A, Powelka AM, Tang X, Virbasius J, Czech MP. 2004. Analysis of insulin signalling by RNAi-based gene silencing. Biochem Soc Trans 32:817-821.